AGP Picks
View all

Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

Press releases published on May 21, 2026

FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND
Brain Cancer Canada Awards The Dwayne Andrews Glioblastoma Research Grant to Tackle One of the Most Aggressive Brain Tumours and Unlock Immunotherapy Breakthroughs for Young Patients
Micron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer
Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis
Palvella Therapeutics Named Healthcare & Life Sciences Company of the Year at the Philadelphia Alliance for Capital and Technologies (PACT) Ecosystem Awards
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes
Vitacore Announces World-First Custom-Fit CPAP Mask Following Health Canada MDL Approval
Zen Leaf Dispensaries Mark 10-Year Las Vegas Anniversary with “All-in-at-10” Community-Focused Celebrations May 21st-May 30th
Picard Medical / SynCardia Reports First Quarter 2026 Financial Results
Hemab Therapeutics Reports First Quarter 2026 Financial Results
Materials Industry Sees $216 Billion in Strategic Investments as AI Infrastructure Drives Next-Generation Material Innovation
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock
Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma
SlimTide Examined: 2026 Consumer-Focused Analysis of Ingredients, Claims, and Label Transparency
JavaTide Examined: 2026 Analysis of Ingredients Profile, Dosage Accuracy, and Metabolic Support Claims

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Essential Healthcare News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.